Menu Search
Equities

Innovate Corp

  • Add to watchlist
  • Add to portfolio
  • Add an alert
PST0:FRA

Innovate Corp

Actions
  • Price (EUR)4.46
  • Today's Change-0.48 / -9.72%
  • Shares traded100.00
  • 1 Year change-61.88%
  • Beta1.6384
Data delayed at least 15 minutes, as of Feb 06 2026 07:11 GMT.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

Innovate Corp. is a diversified holding company. The Company has a portfolio of subsidiaries in a variety of operating segments. Its segments include Infrastructure (DBMG), Life Sciences (Pansend), and Spectrum. The DBMG segment consists of DBM Global Inc., which is a fully integrated construction company offering both construction and professional services primarily through its core subsidiaries. It provides services, including design-assist, modularization, fabrication and erection of structural steel, heavy steel plate, trusses and girders, heavy equipment installation, as well as facility services for maintenance and shutdowns. Life Sciences segment consists of Pansend Life Sciences, LLC, which is focused on supporting healthcare and biotechnology product development. Spectrum segment consists of HC2 Broadcasting Holdings Inc. and its subsidiaries. It owns and operates broadcast television stations throughout the United States.

  • Revenue in USD (TTM)1.10bn
  • Net income in USD-73.10m
  • Incorporated1994
  • Employees3.14k
  • Location
    Innovate Corp295 MADISON AVENUE, 12TH FLOORNEW YORK 10017United StatesUSA
  • Phone+1 (954) 663-1147
  • Fax+1 (302) 636-5454
  • Websitehttps://innovatecorp.com/
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.